載入...
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety of the IVIG IgPro10 (Privigen) for treatment of CIDP, results from Privigen Impact on Mobility and Autonomy (PRIMA), a prospective, open‐label...
Na minha lista:
| 發表在: | J Peripher Nerv Syst |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley Periodicals, Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6594229/ https://ncbi.nlm.nih.gov/pubmed/30672091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12302 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|